Is Merchants Bancorp MBIN stock worth adding exposure to 108 20260420 ABVX Abivax rises 4 percent despite reporting a far wider than expected Q4 2025 pershare loss IRAB Iris management outlines ongoing SPAC target evaluation efforts in its latest quarterly earnings update AI DisruptionDriven CrossSector Equity Volatility Analysis KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss even as shares edge slightly higher